目錄:愛必信(上海)生物科技有限公司>>細(xì)胞生物學(xué)>>重組蛋白>> abs00842Recombinant Human EPOα, Liquid
供貨周期 | 一周 | 規(guī)格 | 500IU |
---|---|---|---|
貨號 | abs00842 |
概述 | |
---|---|
形態(tài) | Sterile filtered liquid in sodium citrate buffer (1 liter of ddH2O containing 5.9 g of sodium citrate, 5.8 g of sodium chloride and 0.06 g of citric acid). |
來源 | CHO |
氨基酸序列 | APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA WKRMEVGA VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGDR |
內(nèi)毒素水平 | Less than 0.01 EU/μg of Recombinant HumanEPO-α as determined by LAL method. |
活性 | Fully biologically active when compared to standard. The Specific Activity was measured by the stimulation of reticulocyte production in normocyth-aemic mice and was found to be no less than 1.5 × 105 IU/mg. |
Accession # | P01588 |
預(yù)期分子量 | Mature human EPO, containing 166 amino acid residues, has a predicted molecular mass of approximay 21 kDa. As a result of glycosylation, the recombinant protein migrates with an apparent molecular mass of 36-40 kDa in SDS-PAGE. |
性能 | |
---|---|
保存方法 | 24 months from date of receipt. Store at 2 to 8 °C under sterile conditions after opening. Do not freeze. |
純度 | > 98 % by SDS-PAGE and HPLC analyses. |
Gene IDs | 2056 |
參考文獻 | |
---|---|
1. Hanicki Z. 1988. Pol Arch Med Wewn, 80: 290-3.<br/>2. Haniu M, Narhi LO, Arakawa T, et al. 1993. Protein Sci, 2: 1441-51.<br/>3. Baranowska-Daca EandKsiazek A. 1994. Ann Univ Mariae Curie Sklodowska Med, 48 Suppl 3: 51-60.<br/>4. Chow KM, Szeto CC, Li PK. 2003. Am J Kidney Dis, 41: 266-7; author reply 7.<br/>5. Maurer MH, Schabitz WR, Schneider A. 2008. Curr Med Chem, 15: 1407-11. |
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)